Loading…
Loading…
Venice, Florida, Feb. 04, 2025 (GLOBE NEWSWIRE) -- LiveCare Inc. (OTCMKTS: LVCE), today announced the resolution of an investigation by the U.S. Department of Justice of allegations related to the Anti-Kickback Statute and the False Claims Act. The resolution was the result of a self-disclosure LiveCare made to the government in July 2023 and the company's cooperation with the Department of Justice throughout its investigation.
Venice, FL, April 11, 2024 (GLOBE NEWSWIRE) -- LiveCare Inc. (OTCMKTS: LVCE), a pioneering force in the telehealth sector, proudly announces a significant financial milestone, having surpassed projections and achieving a recurring monthly revenue of $500,413. This achievement underscores the company's robust growth trajectory and operational excellence. Moreover, LiveCare Inc. is on the verge of reaching profitability expected by the end of April, setting a new benchmark in its financial performance.
Venice, FL, USA, March 19, 2024 (GLOBE NEWSWIRE) -- LiveCare Inc. (OTCMKTS: LVCE), a pioneering force in the Telehealth sector, announces remarkable strides in patient acquisition and recurring monthly revenue growth, marking a significant milestone since the company's strategic overhaul in 2023. This transformation has not only bolstered LiveCare Inc.'s position in the Telehealth industry but also underscored its commitment to helping people and saving lives while enhancing patient care through innovative technology and its 24/7 live monitoring.
Venice, FL, USA, March 05, 2024 (GLOBE NEWSWIRE) -- LiveCare Inc (OTCMKTS: LVCE), a pioneering healthcare technology company providing health coaches with 24/7 support to seniors with diabetes and high blood pressure, is thrilled to announce the unprecedented success of its innovative Blood Pressure Cuff, marking a significant milestone in the management of high blood pressure, particularly among individuals with diabetes. This cutting-edge device has not only expanded the company's market reach but has also positioned LiveCare Inc as a leader in non-invasive health monitoring solutions.
Venice, FL, USA, Feb. 28, 2024 (GLOBE NEWSWIRE) -- LiveCare Inc. (OTCMKTS: LVCE), a leading innovator in healthcare solutions, proudly announces the launch of a state-of-the-art blood pressure cuff device. This device represents a significant step forward in combating high blood pressure, a prevalent condition affecting roughly one-third of adults in the United States. Specifically designed for individuals with high blood pressure, congestive heart failure, hypertension, and diabetes, this cutting-edge device offers a convenient and effective way to monitor health.
Venice, FL, USA, Feb. 20, 2024 (GLOBE NEWSWIRE) -- LiveCare Inc. (OTCMKTS: LVCE), a leading telehealth company specializing in health coaching and comprehensive services for individuals with diabetes, is thrilled to announce significant achievements and future goals. The company has reported a current revenue of $3.3 million, with an ambitious projection of $12 million for the fiscal year 2024, showcasing an unparalleled growth trajectory in the telehealth sector.
Venice, FL, USA, Jan. 16, 2024 (GLOBE NEWSWIRE) -- LiveCare Inc. (OTC:LVCE), a prominent leader in telehealth and remote patient monitoring, announces stellar patient growth and achievements by its patient acquisition team. Initiating its in-house patient acquisition program with just 4 veteran sales agents, LiveCare has now grown its team to 17 highly trained sales agents in three short months. On January 10, 2024, LiveCare recorded its single best day of patient acquisitions by signing up 52 new patients to the Company's patient-centric service. The 52 new patients adds another $7,800 in monthly revenue assuming an average of $150 in billing per patient per month, or nearly $100,000 per annum.
Venice, FL, USA, Dec. 27, 2023 (GLOBE NEWSWIRE) -- LiveCare Inc. (OTC:LVCE), a prominent leader in telehealth and remote patient monitoring, is thrilled to announce significant expansions in its service reach, the addition of a prominent medical expert to its team, and remarkable achievements by its patient acquisition team.
No recent filings indexed.